AeroSafe Blog Breaking it down: Reuse versus single-use direct comparison

Many of the latest clinical breakthroughs are temperature sensitive, leading to significant growth of the pharmaceutical cold chain industry. Immunotherapy, cell and gene therapies, and GLP-1 agonists are all relatively new treatments delivering positive impact for patients. As a result of these product introductions, the cold chain market size is expected to expand by over $10B in the next few years.